Larazotide

What is Larazotide?

Larazotide (also called larazotide acetate or AT-1001) is an 8-amino-acid peptide taken by mouth that is designed to tighten the junctions between the cells lining your gut, in plain terms, to help close a “leaky” gut barrier. It is the furthest along the drug-development path of anything in this section: it has been tested in sizable human clinical trials, mostly in celiac disease. Despite that, it is not FDA-approved. It remains an investigational drug, and it is not something available as a normal supplement or prescription.

What does Larazotide claim to do?

The central claim is that it tightens the gut lining and reduces “leaky gut”, the idea that a too-permeable intestinal barrier lets unwanted substances through and drives inflammation. People hope it can ease symptoms tied to celiac disease (despite a gluten-free diet) and, more speculatively, a range of gut-and-inflammation complaints that get blamed on intestinal permeability.

Why do people use Larazotide?

“Leaky gut” is one of the most discussed concepts in the wellness world, and larazotide is the closest thing to a real drug aimed at that exact target. That gives it strong appeal among people with ongoing celiac symptoms and among biohackers interested in gut-barrier health. Its advanced trial history makes it feel more legitimate than a typical research peptide.

What does the science actually say about Larazotide?

Larazotide has the most formal human research of any peptide in this section. It has gone through multiple clinical trials in celiac disease (including larger, more rigorous studies) testing whether it can reduce symptoms in people who still feel unwell despite a gluten-free diet. Some earlier trials showed encouraging signals on symptoms, which is genuinely notable in a field where most peptides have no trials at all.

But the honest headline is that the pivotal late-stage trial did not clearly succeed, which is a major reason the drug is still not approved. So this is a compound that has been seriously tested in humans and has not yet proven itself well enough to reach the market. That is a more informative outcome than “untested”. It means the simple story didn’t hold up cleanly under rigorous testing.

For the broader, fuzzier “leaky gut” claims beyond celiac disease, the evidence is thinner still. The concept of intestinal permeability is real and studied, but using larazotide as a general gut-sealing supplement is not something human trials support.

How do people use Larazotide?

For information only: in trials larazotide was taken orally as a small dose before meals, with doses reported in the low-milligram range a few times a day. Because it is an investigational drug rather than a sold supplement, there is no legitimate consumer protocol, and any material obtained outside a trial is of unknown identity and quality.

Is Larazotide safe? Risks and who should skip it

In its trials larazotide was generally well tolerated, with mostly mild digestive side effects, which is reassuring as far as it goes. But it is not an approved or readily available product, so anything sourced informally carries serious identity and purity risk. Crucially, celiac disease is a real medical condition that requires a strict gluten-free diet and physician care, larazotide is not a substitute for that, and was only ever studied as an add-on. Pregnant or breastfeeding people and anyone with a gut or autoimmune condition should defer entirely to a doctor.

The bottom line on Larazotide

Larazotide is the most thoroughly tested peptide in this section, which is a point in its favor, but its biggest trial came up short and it remains unapproved. It is a fascinating window into the science of the gut barrier, not a leaky-gut cure you can or should go buy.